Cormorant Asset Management, LP Otonomy, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$2.49 - $6.23 $6.47 Million - $16.2 Million
-2,600,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$3.48 - $6.47 $2.23 Million - $4.15 Million
-641,800 Reduced 19.8%
2,600,000 $16.8 Million
Q3 2020

Nov 16, 2020
BUY
$3.16 - $4.36 $10.2 Million - $14.1 Million
3,241,800 New
3,241,800 $13.1 Million

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email